TIVA-A Rational Approach

download TIVA-A Rational Approach

of 11

Transcript of TIVA-A Rational Approach

  • 1Total Intravenous Anesthesia:

    A Rational Approach to Anesthetic Management

    Michael Rieker, DNP, CRNADirector, Nurse Anesthesia Program

    Wake Forest University Baptist Medical Center

    Objectives

    Review drugs and methods in TIVA Discuss how propofol has aided administration of TIVADescribe different equipment that makes administration of TIVA safe and effectiveList new drugs and drug combinations that are used to improve TIVAOutline medical conditions, disease processes and types of surgery that lend themselves to TIVA for GADiscuss contraindications to TIVA for GA

    Drug administration

    Intravenous agents administered by manual bolus on a dose/kg basis is probably as old-fashioned as administration of volatile agents by the Schimmelbusch mask.Armin Holas MD, University of Graz, Austria.

    IV Anesthesia History Timeline

    Pent

    otha

    l

    Fent

    anyl

    Keta

    min

    e, In

    nova

    rAl

    fant

    anil,

    Suf

    enta

    nil

    Pent

    otha

    l Inf

    usio

    n

    Prop

    ofol

    , Rem

    i, TC

    I

    1930 1950 1970 1990

    Why Intravenous anesthetics?

    SafetyHemodynamic controlRapid titrationAvoid vasodilatation, expansion of gas cavitiesReduced PONVOccupational exposureSmooth emergence, less hangoverAvoid MH riskCost benefit?

    Why Intravenous Anesthetics?

    Improved mucociliary transportLedowski. Anesth Analg. 2006;102(5):1427-30.

    Reduced PONVRohm. Acta Anaesth Scand. 2006 50(1):14-8.

    Less effect on hepatic enzymesRohm. Europ J Anaesth. 2005 ;22(3):209-14.

  • 2Advantages of TIVA

    Improved V/Q matchingPraetel. Anesth Analg. 2004; 99(4):1107-13

    Better preservation of cerebral autoregulation vs. volatile

    Ishikawa, Masui. 2003;52(4):370-7

    McCulloch Anesthesiology. 2007;106(1):56-64

    Reduced stress response.Ledowski Anesth Analg. 2005;101(6):1700-5.

    Advantages of TIVA over balanced

    Improved surgical field (bleeding)Wormald, P, Am J Rhinology 2005;19 (5): 514.

    Volatiles assoc. with inc. inflammation and dec. immune function

    Ken Plitt, BIS lecture.

    Improved CPP, less interference with SSEP, MEP, AEP; Minimal post-op side-effects; potential neuroprotective effects via antioxidant properties.

    Hans, P, Current Op Anaes. 2006;19(5):498-503.

    Not a panacea

    + Titratable, but no diff in shivering, PONV, HTN.

    Wong AY. Eur JAnaes 2006;23(7):586-90

    Cost. (But less PONV)Rohm KD. Acta Anaesthesiologica Scandinavica. 2006;50(1):14-8

    Propofol: wonder drug of the 90s

    Early (emergence)- Rapid and predictable

    Intermediate- Early return of cognitive and psychomotor function. Early time to discharge (?)

    Brady. AANA Journal. 2005;73(3):207-10

    Low incidence of PONVPurhone. Journal of Clinical Anesthesia. 2006;18(1):41-5.

    Recovery profile of propofolStages of recovery after anesthesia

    Reduced risk of postoperative vomitingMeta-analysis of studies: propofol vs volatiles

    4.0

    3.0

    2.0

    1.0

    Allinhalational

    agentsIsoflurane

    (maintenance)Desflurane

    or sevoflurane(maintenance)

    3.7 3.7

    2.3

    70 studiesp < 0.0001

    42 studiesp < 0.0001

    6 studiesp = 0.003

    Reduction in risk of vomiting

    after Diprivan(induction and maintenance)

    n = 4,074

    Sneyd JR et al.Sneyd JR et al. Eur J Anaesthesiol;1998, 15(4), pp 433-445

  • 3Frequency of Side-Effects with Propofol

    0.3

    0.3

    0.4

    1.1

    1.3

    1.9

    5.2

    0 2 4 6

    HTN

    Pain

    Brady

    Hypotension

    Excitement

    N/V

    Pain on Inj

    McLeskey et. al. Anesth Analg 1993;77:S3-9

    Why infusions?

    Avoid over and undershoot of dosageAvoid latency in reaching effect siteReduce workload intraoperativelyContinuous infusions reduce total drug usage by 25-50%More rapid awakeningLess respiratory depressionDischarge times reduced 30%1

    1White PF. Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia. Anesthesiology. 59(4):294-300, 1983.

    Why infusions?

    Avoid over and undershoot of dosageAvoid latency in reaching effect site

    Latency in reaching effect site

    Calculated blood and effect site (brain) concentrations following the bolus administration of propofol, 2.5 mg/kg over 60 seconds

    Russell, D. Practical Aspects of Target-Controlled Infusion. AnaesthesiaRounds Oxfordshire, UK, TMG Healthcare Communications Ltd. P. 3.

    Why infusions?

    Reduce workload intraoperativelyReduce total drug usage by 25-50%

    Why infusions?

    More rapid awakeningLess respiratory depression

  • 4Why infusions?

    Discharge times reduced 30%White PF. Anesthesiology. 1983;59(4):294-300.

    Patients met PACU discharge criteria 30 minutes faster with TIVAMontes. Journal of Clinical Anesthesia 2002;14(5):324-8.

    Reliability of discharge improvement

    Faster readiness, but discharge and cost savings are depending upon system

    Montes, Flix R (2002). "Comparison of total intravenous anesthesia and sevoflurane-fentanyl anesthesia for outpatient otorhinolaryngeal surgery." Journal of clinical anesthesia, 14 (5), p. 324.

    Why now?

    Historical perspectiveInhalation anesthesia

    RGM, neuromonitors

    concentration-controlled vaporizers

    open drop ether mask

    Best

    Better

    Good

    Titrate to effect-site concentration and response

    Deliver MAC level

    Strength of pulse

    Why now?

    Historical perspectiveIntravenous anesthesia

    Rapid recovery drugs, target-controlled infusion pumps

    Infusion pump

    IV bolus

    Best

    Better

    Good

    Titrate to effect-site concentration and response

    Titrate according to context-specific half-time

    Estimate time for recovery, based on t1/2

    Why now? TIVA equipment

  • 5Why now? Specific indicationsfor TIVA

    Need for precision controlAirway proceduresRemote locationsMH susceptibleNeurosurgeryNeuro monitoringPONV risk

    Effect on PONV

    PONV similar between Propofol TIVA and Sevo + Dolasetron in high-risk patients. Late PONV was worse in TIVA group.

    White, British Journal of Anaesthesia. 98(4):470-6, 2007

    PONV similar between TIVA without anti-emetic and volatile + anti-emetic

    Paech Anaesth Intensive Care 30:1539

    TIVA (without N2O) equally effective as any anti-emetic as independent factor reducing PONV

    Apfel N Engl J Med 350:244151

    Disadvantages

    Acquisition costsControlled substance accountingSet-up and use greater workload than

    vaporizersEarly or late respiratory depressionOpioid side-effects- biliary, muscle rigidity,

    GI motility, pruritusAdverse events if IV line disrupted

    Infusion administration

    Rapid recovery drugs, target-controlled infusion pumps

    Infusion pump

    IV bolus

    Best

    Better

    Good

    Titrate to effect-site concentration and response

    Titrate according to context-specific half-time

    Estimate time for recovery, based on t1/2

    Forget about elimination half-life

    A useless measure to guide anesthetic administrationAs many half-lives as distribution

    compartmentsTakes no account of time course at effect

    sitePentothal- half-life = hours

    duration = depends on administration i.e., depends on CONTEXT

  • 6Open three-compartment PK model Context-sensitive half-time

    Duration of a drugs effects depends on way its administered

    Hughes MA. Glass PS. Jacobs J:. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 76(3):334-41, 1992.

    Context-sensitive half-time

    Sneyd, Recent Advances in Intravenous Anaesthesia. Br J Anaesth 2004 93(5):725-736

    Context-sensitive alterations in propofol kinetics

    Russell, D. Practical Aspects of Target-Controlled Infusion. AnaesthesiaRounds Oxfordshire, UK, TMG Healthcare Communications Ltd. p. 10.

    Context-sensitive half life vs. necessarydecrease

    Shafer SL. Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 74(1):53-63, 1991.

    Key effect site concentration levels

    0.251251.5Adequate Ventilation

    2-81000-400015-60O2 only0.25-1.0100-7501.5-10O2/N2O only0.25-0.5100-3001.5-4N2O/Vapor

    Maintenance0.8-1.2400-7508-10O2/N2O only0.4-0.6250-4003-5 ng/mlThiopental

    Induction and IntubationSufentanilAlfentanilFentanyl

  • 7Context-sensitive half life vs. necessary decrease

    Shafer SL. Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 74(1):53-63, 1991.

    0.25Ventilation

    2-8O2 only

    0.25-1.0O2/N2O only

    0.25-0.5N2O/Vapor

    Maintenance

    Sufentanilng/ml

    But thats the old-fashioned way

    Target-controlled infusions eliminate all that thinkingComputer-driven infusion pumps are programmed with pharmacokinetic data for specific drugs in a range of patient types. The anesthetist sets the desired blood level, and the pump does the rest.

    Variants of TCI terminology

    CATIA- Computer Assisted Total Intravenous AnaesthesiaTIAC- Titration of Intravenous Agents by ComputerCACI- Computer Assisted Continuous InfusionCCIP- Computer Controlled Infusion Pump

    TCI equipment

    TCI equipment

    Pharmacokinetics a validated model with specific parameters for drugAlgorithm(s) to control infusion rateControl unit i.e. software and

    microprocessors for aboveInfusion pumpUser interface for input of patient data and

    target blood concentration

    Key components of a TCI system

  • 8Measured versus calculated blood propofolconcentrations during Diprifusor TCI administration of propofol in 46 patients.

    Russell, D. Practical Aspects of Target-Controlled Infusion. AnaesthesiaRoundsOxfordshire, UK, TMG Healthcare Communications Ltd. P. 3.

    Software program Commercially available

    Diprifusor TCI systems. (a) Graseby 3500.(b) Vial Medical Master TCI(c) Alaris IVAC TIVA TCI(d) Terumo Terufusion TE-

    372 TCI TIVA

    Diprifusor

    Loading dose schemes by Diprifusor

    Russell, D. Practical Aspects of Target-Controlled Infusion. Anaesthesia Rounds Oxfordshire, UK, TMG Healthcare Communications Ltd. P. 7

    Cardiac induction by Diprifusor

    Russell, D. Practical Aspects of Target-Controlled Infusion. AnaesthesiaRounds Oxfordshire, UK, TMG Healthcare Communications Ltd. p. 8.

    TCI safety mechanisms

    Validated pharmacokineticsCompensation for interrupted infusionAutomatic shutdown in case of malfunctionElectronic tags on pre-filled syringes

    (diprivan) to prevent wrong-drug in pump

    Tagged, prefilled syringes for use with Diprifusor target-controlled infusion systems

  • 9TCI Displays TCI Displays

    TCI Evaluation Inaccuracies

    Limits: age 16-100 for conventional programs. Weight 30-150 kgDoes not account for ethnopharmacology (cannot distinguish a Kenyan African from an Italian)Head injuryConcomitant medsNo problem

    HypoalbuminemiaRapid fluid admin

    Practical application of TIVA

    Select drugs to be used Timing is everything- consider effect site peak

    and Co-inductionHigher index of vigilance for recall- reduce

    muscle relaxation, awareness monitorTitrate infusions based on context-specific

    half-time

    Opioid infusion schemes

    0.4-1.00.020.01

    0.0031.0

    0.250.700.20

    Infusion Rate g/kg/min

    N20/narc1-215analg16Remifentanil

    N20/narc0.50.5Bal0.150.15Sufentanil

    Bal/N2080160 Analg2040Alfentanil

    N20/narc104Bal31Fentanyl

    UseBolus g/kg

    Plasma Target Conc

    (ng/ml)

    Drug

  • 10

    Propofol context-sensitive dosing

    Propofol only TIVA: Induce 2-2.5mg/kg, then infuse:

    150-300 g/kg/min first 10 minutes 120-240 10 min to 2 hours75-150 beyond 2 hours

    Propofol + opioid: Induce 1.5-2mg/kg, then100-150 first 10 minutes 90-140 10 min to 2 hours75-125 beyond 2 hours

    Ketamine infusion dosing

    Induction: 0.75-2mg/kgInfusion 1-2 mg/kg/hrMidazolam 3-5 mg load, then 0.25 g/kg/min

    Pre-mixed maintenance infusion400 mg ketamine + 4mg midazolam in 100ml saline

    Infuse at 0.5 x weight in kg = ml/hrz = 2mg/kg/hr ketaminez = 0.33 g/kg/min midazolam

    Propofol-Ketamine infusion

    Extensive use in outpatient (office) settings with outstanding track record for safety and lack of side-effects.

    Mix ketamine 2mg/ml of propofolInduce with 1-2mg/kg propofol in mixtureGive additional 0.5-1mg/kg ketamine after asleepInfuse 140-200 g/kg/min first 10 minutes (based on propofol)

    100-140 g/kg/min for next 2 hours 80-120 g/kg/min after 2 hours

    Remifentanil Infusion

    Boon to all types of anesthesiaFast onset and recovery; independent of

    infusion durationTurn pump on at 1 g/kg/min

    Also start propofol bolus via pump, or wait 30 sec to injectMaintain at 0.1-0.3 g/kg/min for target plasma concentration of 5ng/mlTurn off 5-7 min before extubation. Extubatequickly upon awakening

    Propofol-Alfentanil TIVA

    Induce Propofol 0.5-1mg/kg Alfentanil 25-50 g/kg

    MaintenancePropofol 100-180 g/kg/minAlfentanil 0.5-2 g/kg/min

    Dosages loosely suggested; account for level of stimulation and concurrent meds i.e., midazolam

    Future of TIVA

    Closed-loop anesthesiaDrug advances

    S+ ketamine enantiomerPropofol pro-drugNew hypnotics (THRX-918661)

    Non-invasive monitoring of propofol blood concentration

  • 11

    Its all getting so easy, but maybe tooeasy? The Aneo TIVAS system

    Summary

    TIVA techniques can provide numerous advantages over volatile-based anesthetics.While equipment set-up and cost is greater than using existing vaporizers, long-term savings can be appreciated.Context-sensitive PK considerations allow safe and effective narcotic dosing.Modern infusion technology and TCI lends control to IV techniques to rival vaporizer use. More info: UK Society for Intravenous Anaesthesiawww.sivauk.org